Fig. 2From: Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytomaCGMS tracings taken over 1 week after initiation of everolimus. Each color represents an individual dayBack to article page